Valeant Pharmaceuticals International Begins Trading Under NYSE Ticker Symbol VRX COSTA MESA, Calif., Nov. 14 /PRNewswire-FirstCall/ -- Valeant Pharmaceuticals International announced that it will begin trading today on the New York Stock Exchange under ticker symbol VRX. The company previously traded under the symbol ICN. The new ticker symbol is a result of the company's recent name change to Valeant Pharmaceuticals International on November 12, 2003. The company was formerly known as ICN Pharmaceuticals, Inc. About Valeant Valeant Pharmaceuticals International (NYSE:VRX) is a global, publicly traded, research-based specialty pharmaceutical company that discovers, develops, manufactures and markets a broad range of pharmaceutical products. More information about Valeant can be found at http://www.valeant.com/. For further information please contact: Jeff Misakian of Valeant Pharmaceuticals, +1-714-545-0100, ext. 3309. DATASOURCE: Valeant Pharmaceuticals International CONTACT: Jeff Misakian of Valeant Pharmaceuticals, +1-714-545-0100, ext. 3309 Web site: http://www.valeant.com/

Copyright